MedTrace Logo

Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts

NCT05100043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-02-19

No results posted yet for this study

Summary

In the present study the investigators assessed the invitro role of IL-4 and IFN-γ in predicting the response to bivalent HPV vaccine after whole blood stimulation

Conditions

  • Warts Hand
  • Wart, Genital

Interventions

BIOLOGICAL

IL-4 and IFN-γ measurements

Blood samples are withdrawn from participants and whole blood cultures are prepared and stimulated by bivalent HPV vaccine.IL-4 and IFN-γ are measured in culture supernatants

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • Ayman Marei, MD, PhD · Faculty of Medicine, Zagazig University , Zagazig, Egypt

Eligibility

Min Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-03
Primary Completion
2020-07-03
Completion
2021-03-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100043 on ClinicalTrials.gov